Chimerix Investor Relations Material
Latest events
FDA Announcement
Chimerix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chimerix Inc
Access all reports
Chimerix Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for life-threatening diseases, including viral infections and cancer. The company's portfolio includes antiviral treatments and oncology therapies aimed at addressing unmet medical needs. Chimerix works on developing novel drug candidates to improve outcomes for patients with limited treatment options, particularly in areas such as immunotherapy and targeted therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Key slides for Chimerix Inc
FDA Announcement
Chimerix Inc
FDA Announcement
Chimerix Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CMRX
Country
🇺🇸 United States